Solid forms comprising 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one and a coformer
US9512129B2 · kind B2 · utility
3Cited by
21References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 15, 2015 |
| Grant date | Dec 6, 2016 |
| Priority date | — |
| Expiry date | Jun 8, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.